Financial Year |
March 31 2023 |
Monetary Funds |
585,803,064.22 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
8,783,370.00 |
Accounts Receivable |
634,563,702.00 |
Advances to Suppliers |
74,923,201.05 |
Other Receivables |
5,185,568.54 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
84,655,933.76 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
8,464,061.35 |
Total Current Assets |
1,402,828,900.92 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
7,897,648.42 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
661,757.84 |
R&D expenses |
-- |
Goodwill |
865,400.38 |
Long-Term Deferred and Prepaid Expenses |
1,851,515.26 |
Deferred Income Tax Assets |
2,312,990.37 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
17,269,122.91 |
Total Assets |
1,420,098,023.83 |
Short-Term Loans |
79,700,779.34 |
Trading Financial liabilities |
-- |
Notes Payable |
49,373,305.00 |
Accounts Payable |
175,731,712.94 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
14,871,631.96 |
Taxes Payable |
33,266,302.89 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
34,275.30 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,330,861.38 |
Other Current Liabilities |
989,586.84 |
Sub-Total of Current Liabilities |
367,345,699.06 |
Long-term Loans |
-- |
Bonds Payable |
234,607,154.00 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
1,560.00 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
236,326,039.44 |
Total Liabilities |
603,671,738.50 |
Paid-In Capital(Or Share Stock) |
80,000,000.00 |
Capital Surplus |
470,163,940.66 |
Surplus Reserve |
20,139,283.15 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
228,373,052.60 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
816,426,285.33 |
Owner's Equity(Stockholder's Equity) |
816,426,285.33 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,420,098,023.83 |